Ratings by Rodman & Renshaw (Brandon Folkes)

More Stocks Rated by Rodman & Renshaw
Date CompanySymbol Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/25/2025 CorMedix CRMD Maintain Buy
(N/A)		  
 		   Details
3/10/2025 Trevi Therapeutics TRVI Maintain Buy
(N/A)		  
 		   Details
3/4/2025 Adial Pharmaceuticals Inc ADIL Maintain Buy
(N/A)		  
 		   Details
1/28/2025 Cardiol Therapeutics CRDL New Coverage Buy
(N/A)		 1.29
(1.12)		 -13.18% Details
1/28/2025 Indivior INDV New Coverage Buy
(N/A)		 12.02
(34.47)		 186.77% Details
1/28/2025 Rein Therapeutics RNTX New Coverage Buy
(N/A)		 2.10
(0.58)		 -72.38% Details
1/28/2025 PolyPid Ltd. PYPD New Coverage Buy
(N/A)		 3.15
(5.25)		 66.67% Details
1/28/2025 Talphera TLPH New Coverage Buy
(N/A)		 0.72
(1.08)		 50% Details
11/14/2024 Rockwell Medical Technologies RMTI New Coverage Buy
(N/A)		 2.63
(6.94)		 163.88% Details
11/14/2024 Eupraxia Pharmaceuticals EPRX New Coverage Buy
(N/A)		 2.84
(6.87)		 141.9% Details
11/14/2024 Achieve Life Sciences ACHV New Coverage Buy
(N/A)		 4.53
(6.49)		 43.27% Details
11/14/2024 Adial Pharmaceuticals Inc ADIL New Coverage Buy
(N/A)		 0.99
(3.92)		 295.96% Details
11/14/2024 Omeros Corp. OMER New Coverage Buy
(N/A)		 4.19
(16.57)		 295.47% Details
8/26/2024 CorMedix CRMD New Coverage Buy
(N/A)		 5.65
(7.85)		 38.94% Details
6/13/2024 Trevi Therapeutics TRVI New Coverage Buy
(N/A)		 2.60
(12.61)		 385% Details
6/13/2024 Scilex Holding Co. SCLX New Coverage Buy
(N/A)		 1.33
(2.35)		 76.69% Details
6/13/2024 Heron Therapeutics HRTX New Coverage Buy
(N/A)		 3.64
(0.30)		 -91.76% Details
6/13/2024 Rani Therapeutics Holdsing s RANI New Coverage Buy
(N/A)		 4.01
(0.61)		 -84.79% Details
6/13/2024 MannKind MNKD New Coverage Buy
(N/A)		 4.65
(3.19)		 -31.4% Details